GDUFA Research Outcomes
Peptide APIs
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to complex active pharmaceutical ingredients that are peptides, including associated impurities in generic products.
-
Considerations in Developing Generic Peptide and Oligonucleotide Drug Products
Zhang, Deyi
-
Characterization and Comparative Evaluation Strategies to Demonstrate Complex API Sameness
Zhang, Deyi
-
Considerations in Demonstrating Complex API Sameness
Zhang, Deyi
-
Demonstrating Complex API Sameness
Zhang, Deyi
-
Guidance for Peptide Products and Assessing Immunogenicity Risk
Pang, Eric
-
Resolving Peptide Drug Challenges Through Pre-ANDA Processes
Pang, Eric
-
An Overview of Challenges and Opportunities for Innovation in Complex Generic Drug Product Development
Jiang, Xiaohui
-
Non-clinical Evaluation of Comparative Immunogenicity Risk of Complex Peptide Products
Pang, Eric
-
Follow up Discussion on FDA Peptide Guidance after Public Comments
Jiang, Jeff
-
Current Thinking on Synthetic Peptides in Abbreviated New Drug Applications
Jiang, Jeff